Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +6.30% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.27 | N/A | +6.30% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their product pipeline and market position. They emphasized the importance of innovation in maintaining competitive advantage.
Management highlighted strong demand for their vascular products.
They noted ongoing investments in R&D to drive future growth.
Lemaitre Vascular's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The company did not provide revenue figures or future guidance, leaving investors with limited information on growth expectations. The stock's modest rise reflects cautious optimism among investors following the earnings announcement.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KBR INC